Optometrists’ ability to classify retinal lesions for retreatment decisions regarding neovascular age-related macular degeneration is not inferior to that of ophthalmologists. Medscape Medical News
Tag: News
Patch Unnecessary for Corneal Abrasions
Patching corneal abrasions did not improve healing, pain, analgesic use, symptoms, or complication rates compared with not patching abrasions. Medscape Medical News
Nepafenac Prevents Macular Edema Associated With Cataract Surgery
Nepafenac, administered topically as eyedrops, prevents macular edema after cataract surgery in patients with diabetic retinopathy, researchers report. Reuters Health Information
Vitreous Injection New Option for Postoperative Cataract Care
A single transzonular vitreous injection was just as effective as standard topical therapy after cataract surgery. Medscape Medical News
Retinal Thinning a Marker for Cognitive Decline?
Thinning of the retinal nerve fiber layer is associated with poor cognitive function and may be a clinical marker for cognitive decline, a large study shows. Medscape Medical News
Endophthalmitis Risk Low After Intravitreal Injection
The risk for endophthalmitis after intravitreal injection was low, and prophylactic topical antibiotics did not appear to decrease this risk, according to results of a study of more than 90,000 injections. Medscape Medical News
Scant Patient Input Collected in Glaucoma Device Evaluation
Studies of minimally invasive glaucoma surgical (MIGS) devices do not pay sufficient attention to patient-centered outcomes such as adverse events and visual acuity, according to Maryland-based researchers. Reuters Health Information
Scientists Regrow Severed Nerves in Mice, Restore Vision
Visual stimulation with growth-promoting gene therapy helped retinal neurons regrow and restored some vision after injury, a study showed. It has ‘tremendous’ clinical implications, authors said. Medscape Medical News
Expensive Eye Meds Cost Medicare ‘Billions’
Many U.S. ophthalmologists are prescribing expensive eye medications for Medicare patients despite evidence that a lower cost drug may be just as effective, researchers report. Reuters Health Information
Eye Test Screens for Traumatic Brain Injury, Concussion
A 10-minute test using a handheld pupillometer and a questionnaire successfully picked up signs of mild traumatic brain injury in military personnel. Medscape Medical News
More Evidence Latanoprostene Bunod Lowers Ocular Pressure
The dual-acting investigational antiglaucoma agent improves outflow through both uveoscleral and trabecular meshwork pathways, report investigators. Medscape Medical News
Smartphone Use in Bed ‘Causes Temporary Blindness’
Using your smartphone in bed in the dark can cause a temporary loss of vision, eye experts are warning. WebMD Health News
Industry Incentives May Drive Pricier Anti-VEGF Drug Use
Ophthalmologists with the most and largest payments had highest rates of injection with aflibercept and ranibizumab. Medscape Medical News
USPSTF Diabetes Screening Recommendations Are Cost-effective
The guideline means more people will be screened but it will still be of value, said an economist. Medscape Medical News
Faster Glaucoma Progress Tied to Higher Fall Rate
Glaucoma patients with rapid visual field (VF) loss are at greater risk of falls than those with slower progression, new research shows Reuters Health Information
Obesity Surgery in Diabetics May Mean Less Eye and Nerve Damage
Patients whose type 2 diabetes improves after bariatric surgery may also be less likely to suffer microvascular complications, a U.S. study suggests. Reuters Health Information
Eye Benefits Last 4 Years Past Tight Glucose Control: ACCORDION
In this ACCORD follow-up in patients with longstanding type 2 diabetes plus cardiovascular disease, intensive glycemic control reduced the risk of retinopathy progression years later, in a “legacy effect.”
Medscape Medical News
Poll: Ophthalmologists Eager to Use Corneal Crosslinking
A Medscape poll finds US ophthalmologists eager to access the newly FDA-approved keratoconus treatment that the majority of the world has enjoyed for some time. Medscape Medical News
Two Expensive Diabetic Macular Edema Drugs Not Cost-effective
Anti-VEGF medicines aflibercept and ranibizumab would have to drop in price by 69% and 80%, respectively, to be worth the societal cost compared with bevacizumab, a new study has found. Medscape Medical News
Eye and Kidney Damage in Diabetes Tied to Heart Problems
Diabetes complications like eye, kidney and nerve damage can all increase the odds of hospitalizations and death from heart problems, a recent study suggests. Reuters Health Information